Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to $15.0 million.

  • Abeona Therapeutics' Non-Current Assets rose 8859.48% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.3 million, marking a year-over-year increase of 4893.22%. This contributed to the annual value of $8.1 million for FY2024, which is 226.26% down from last year.
  • Per Abeona Therapeutics' latest filing, its Non-Current Assets stood at $15.0 million for Q3 2025, which was up 8859.48% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Non-Current Assets registered a high of $52.8 million during Q1 2021, and its lowest value of $7.9 million during Q3 2024.
  • For the 5-year period, Abeona Therapeutics' Non-Current Assets averaged around $18.1 million, with its median value being $11.2 million (2025).
  • As far as peak fluctuations go, Abeona Therapeutics' Non-Current Assets crashed by 7405.02% in 2022, and later soared by 8859.48% in 2025.
  • Abeona Therapeutics' Non-Current Assets (Quarter) stood at $23.3 million in 2021, then crashed by 52.28% to $11.1 million in 2022, then fell by 25.64% to $8.3 million in 2023, then decreased by 2.26% to $8.1 million in 2024, then soared by 85.26% to $15.0 million in 2025.
  • Its Non-Current Assets was $15.0 million in Q3 2025, compared to $14.0 million in Q2 2025 and $11.2 million in Q1 2025.